VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CHE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CHEChemed Corporation
$546.75$7.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
CHE logo

Chemed Corporation

CHE
NYSE · Healthcare Providers
$546.75
At close - Nov 17, 4:00 PM EST - USD
Market Cap$7.26B
P/E25.4x
52W High$562.24
Volume147.56K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q3

Revenue Reaccelerates as Debt-Funded Buybacks Tighten Liquidity

Chemed's revenue growth reaccelerated to 10.6% year-over-year in Q3 2026, up from a 1.6% trough in Q1 2026, with gross margins recovering to 33.7% from a 28.9% low in Q3 2025, suggesting the mid-2025 deceleration proved transitory as SG&A leverage improved from roughly 16.7% to 16.1% of revenue.

GrowthMixed
ProfitabilityModerate
ValuationExpensive
TechnicalsStrong
Explore valuation models
MARKET ACTION

CHE price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

6/12 Beats

EPS beat 6 of last 12 quarters

02

Valuation risk

+25% Peers

P/E is 25% above peer median

03

Market leadership

RS 80 · Leader

High momentum (Outperforming 80% of market)

04

Strong Uptrend

Strong Trend

Price > 20DMA > 50DMA > 200DMA

Next CatalystEstimated earnings · Jan 27
01

Build the investment case

Start with the evidence for owning the stock and the risks that can break the thesis.

EXECUTIVE THESIS

The Investment Case

Full Analysis
Fundamental Trajectory

Revenue growth reaccelerated to 10.6% year-over-year in Q3 2026 with gross margin recovering to 33.7% from a 28.9% trough, though margins remain 290 basis points below the 36.6% Q4 2024 peak as labor costs and reimbursement mix continue to pressure profitability.

Analyst Consensus+16.1% target
Buy(10 analysts)
5 Buy5 Hold0 Sell

The Bull Case

Upside Catalysts

Durable earnings profile

Chemed Corporation has a durable earnings profile, which is a key driver of its bullish investment case.

Volatility-driven share repurchases

The company benefits from volatility-driven share repurchases, enhancing shareholder value.

Disciplined capital allocation

Chemed Corporation demonstrates disciplined capital allocation, contributing to its strong financial performance.

The Bear Case

Key Downside Risks

Market performance

Price History →

Trailing total returns as of 11/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
CHE+29.63%
S&P 500 (^GSPC)+7.21%
1-Year Return
CHE+27.19%
S&P 500 (^GSPC)+10.03%
3-Year Return
CHE-4.89%
S&P 500 (^GSPC)+62.77%
5-Year Return
CHE+10.15%
S&P 500 (^GSPC)+55.03%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y Low
25.4x
Forward P/EExpansion
21.2x
EV/EBITDA20th %ile
16.7x
FCF YieldCash Flow
4.1%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
25.4x
30.9x
20th· Low
EV/EBITDA
16.7x
19.6x
20th· Low
Price/FCF
24.6x
30.5x
40th· Fair
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$245.93-55.0%
Base (Fair)$433.88-20.9%
Bull$598.79+9.5%
$245.93 Bear$433.88 Base$598.79 Bull
Current Market Price: $546.75
Trades at a 26.0% premium to Base DCF ($433.88)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$2.53B+4.1% YoY
Net income FY25
$265M-12.2% YoY
Free cash flow FY25
$325M-11.5% YoY
Operating margin FY25
13.4%-1.7 pts YoY
ROIC (FY25)23.7%
Avg ROIC 5Y26.4%
ROE (TTM)32.1%
Piotroski Score5 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate6/12 (50%)
Revenue Beat Rate5/12 (42%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Oct 27, 2026
$6.75+4.8%
vs $6.44
$691M+0.9%
vs $685M
Q3 2026
Jul 28, 2026
$6.06+8.2%
vs $5.60
$673M+1.2%
vs $665M
Q2 2026
Apr 23, 2026
$5.65+6.6%
vs $5.30
$658M+1.2%
vs $650M
Q1 2026
Feb 25, 2026
$6.42-8.5%
vs $7.02
$639M-3.0%
vs $659M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Zacks Investment Research·Nov 10, 2026
Here's Why Chemed (CHE) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Seeking Alpha·Nov 9, 2026
Chemed Corporation (CHE) Presents at 2026 UBS Global Healthcare Conference Transcript

Chemed Corporation (CHE) Presents at 2026 UBS Global Healthcare Conference Transcript

GlobeNewsWire·Nov 6, 2026
Chemed Corporation Declares Quarterly Dividend of 70 Cents

CINCINNATI, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company's capital stock, payable on December 4, 2026, to shareholders of record as of November 16, 2026. This is equal to the dividend paid in September 2026.

Zacks Investment Research·Nov 2, 2026
Why Chemed (CHE) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Filtered for Chemed CorporationMore Headlines
04

Compare before deciding

Benchmark CHE against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Chemed Corporation (CHE)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
CHE logoCHEChemed CorporationCurrent
$546.75$7.26B25.434.06%10.61%32.1%0.4%
ADUS logoADUSAddus HomeCare Corporation
$121.56$2.27B20.3323.21%7.39%9.81%—
ENSG logoENSGThe Ensign Group, Inc.
$186.02$10.84B27.6418.72%7.03%16.61%0.13%
SCI logoSCIService Corporation International
$73.45$10.15B15.462.93%14.76%41.16%1.75%
CSV logoCSVCarriage Services, Inc.
$28.54$453M9.583.28%11.31%17.23%1.57%
HCSG logoHCSGHealthcare Services Group, Inc.
$24.69$1.69B16.337.08%5.58%20.22%—

Compare CHE vs Peers

Chemed Corporation (CHE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ADUS

Most directly comparable listed peer for CHE.

Scale Benchmark

vs UNH

Larger-name benchmark to compare CHE against a more recognizable public peer.

Peer Set

Compare Top 5

vs ADUS, ENSG, SCI, CSV

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

CHE SEC Filings & Documents

Chemed Corporation (CHE) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Oct 27, 2026·SEC

Material company update

Jul 28, 2026·SEC

Material company update

May 19, 2026·SEC

10-K Annual Reports

4
FY 2026

Feb 27, 2026·SEC

FY 2025

Feb 28, 2025·SEC

FY 2024

Feb 29, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Oct 29, 2026·SEC

FY 2026

Jul 31, 2026·SEC

FY 2026

Apr 28, 2026·SEC

Get notified when CHE posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CHE Frequently Asked Questions

Chemed Corporation (CHE) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Chemed Corporation's revenue?

Chemed Corporation (CHE) reported $2.66B in revenue over the trailing twelve months. Revenue was $2.53B in fiscal year 2025. That is 740% more than the $301.2M of fiscal year 1996.

How fast is Chemed Corporation growing?

Chemed Corporation (CHE) grew revenue by 5.2% over the trailing twelve months, compared with the twelve months before.

Is CHE profitable?

Yes. Chemed Corporation (CHE) earned $282.4M in net income over the trailing twelve months (a 10.6% net margin).

Dividend & Returns
Does CHE pay dividends?

Yes. Chemed Corporation (CHE) pays a dividend that yields 0.40% at the current price, a small yield.

What is CHE's return on equity?

Chemed Corporation (CHE) had a return on equity (ROE) of 32.1% over the trailing twelve months. That is well above the market's typical 10-15%.

What is Chemed Corporation's free cash flow?

Chemed Corporation (CHE) generated $295.5M in free cash flow over the trailing twelve months.

What if you invested $1,000 in CHE back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →